In the USA, people began testing an HIV vaccine: how it works - ForumDaily
The article has been automatically translated into English by Google Translate from Russian and has not been edited.
Переклад цього матеріалу українською мовою з російської було автоматично здійснено сервісом Google Translate, без подальшого редагування тексту.
Bu məqalə Google Translate servisi vasitəsi ilə avtomatik olaraq rus dilindən azərbaycan dilinə tərcümə olunmuşdur. Bundan sonra mətn redaktə edilməmişdir.

In the United States began to test the HIV vaccine on people: how it works

The company announced that the first participants have been vaccinated as part of a phase 1 clinical trial of an experimental HIV vaccine that uses Moderna mRNA technology. CNN.

Photo: Shutterstock

Test titled IAVI G002 is being held in partnership with IAVI, a non-profit research organization. This is a test of a vaccine that delivers specific HIV antigens to the body in order to elicit an immune response. These antigens were originally developed by IAVI and Scripps Research led by Dr. William Schiff.

Last year, in a proof-of-concept trial, the research team found that HIV antigens elicited the desired immune response in 97% of participants. The current test builds on the previous one. Scientists are testing the main version of the vaccine, as well as a booster version, and are also using Moderna mRNA technology, which has previously been used to create a successful Covid-19 vaccine.

On the subject: What to do if you lose or damage your COVID-19 vaccination card

“We are very excited to advance this new direction in HIV vaccine development with the Moderna mRNA platform. The search for an HIV vaccine has been long and complex, and having new tools in terms of immunogens and platforms could be the key to rapid progress toward an effective HIV vaccine,” said Mark Feinberg, President and CEO of IAVI, in a Moderna press release. .

The new trial, funded in part by the Bill & Melinda Gates Foundation, will involve 56 HIV-negative adults to study both the safety and efficacy of the vaccine. Forty-eight volunteers will receive at least one dose of the primary vaccine, 32 of whom will also receive a booster. The remaining eight will receive only the booster vaccine.

You may be interested in: top New York news, stories of our immigrants, and helpful tips about life in the Big Apple - read it all on ForumDaily New York.

The trial involves volunteers from four locations: The George Washington University School of Medicine, Hope Clinic, Emory Vaccine Center, Fred Hutchinson Cancer Research Center, and the University of Texas Health Sciences Center at San Antonio.

Read also on ForumDaily:

Seven years of searching: how a Russian-speaking Jew in the USA invented a vaccine that saved millions of children

Dream job: US company will pay you to sleep

Like in 'The Matrix': Chinese scientists have created robotic wombs to raise children

Miscellanea In the U.S. vaccine ВИЧ Modern
Subscribe to ForumDaily on Google News

Do you want more important and interesting news about life in the USA and immigration to America? — support us donate! Also subscribe to our page Facebook. Select the “Priority in display” option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram  and Instagram- there is a lot of interesting things there. And join thousands of readers ForumDaily New York — there you will find a lot of interesting and positive information about life in the metropolis. 



 
1069 requests in 1,164 seconds.